CytomX Therapeutics, Inc. short interest in 2025
In 2025, CytomX Therapeutics, Inc.'s disclosed short interest ran from 5.92% of shares outstanding on 15 Jan 2025 to 13.92% on 31 Dec 2025, a change of +8.00 percentage points. The year's high was 29.61% on 15 Jul 2025 and its low 5.62% on 14 Feb 2025, averaging 15.33% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.49 days on 31 Jul 2025. Full history: CytomX Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 5.92% (15 Jan 2025)
- End of year
- 13.92% (31 Dec 2025)
- Change
- +8.00 pp
- High
- 29.61% (15 Jul 2025)
- Low
- 5.62% (14 Feb 2025)
- Average
- 15.33%
- Highest days to cover
- 18.49 (31 Jul 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 5.92% | 3.42 | |
| 31 Jan 2025 | 5.82% | 6.15 | |
| 14 Feb 2025 | 5.62% | 6.03 | |
| 28 Feb 2025 | 6.00% | 7.55 | |
| 14 Mar 2025 | 11.51% | 1.39 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 11.95% | 8.99 | |
| 15 Apr 2025 | 12.23% | 7.37 | |
| 30 Apr 2025 | 12.09% | 6.96 | |
| 15 May 2025 | 21.99% | 1.04 | 10-Q filed, results (8-K) |
| 30 May 2025 | 23.52% | 4.36 | |
| 13 Jun 2025 | 25.79% | 8.40 | |
| 30 Jun 2025 | 27.78% | 7.63 | |
| 15 Jul 2025 | 29.61% | 14.60 | |
| 31 Jul 2025 | 14.53% | 18.49 | |
| 15 Aug 2025 | 15.24% | 5.61 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 16.35% | 9.09 | |
| 15 Sep 2025 | 17.56% | 11.31 | |
| 30 Sep 2025 | 19.02% | 5.57 | |
| 15 Oct 2025 | 17.22% | 8.58 | |
| 31 Oct 2025 | 16.95% | 12.11 | |
| 14 Nov 2025 | 17.30% | 5.59 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 10.14% | 7.62 | |
| 15 Dec 2025 | 9.90% | 9.20 | |
| 31 Dec 2025 | 13.92% | 6.56 |
See also: CytomX Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.